Longitudinal Investigation of Sleep, Memory, and Brain Development Across the Nap Transition

ConditionMemory
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age36-60
SponsorUniversity of Maryland, College Park

About this trial

To examine the relations between sleep (nap transitions, sleep physiology), memory, and brain development longitudinally, the researchers will assess n=180 children (in order to acquire n=152 usable data sets) who are 36-54 months of age and habitual nappers at enrollment. In each wave, the researchers will assess memory, memory change over a nap and equivalent waking interval, sleep physiology of the nap, and brain structure and function (using Magnetic Resonance Imagining or MRI). Additionally, overnight sleep physiology will be assessed in all participants. Waves will take place approximately every 6 months. For all children, three waves will be collected. With these data, the researchers will address the following aims:

* Examine neural markers that predict the sleep transition (Aim 1); * Examine changes in sleep-dependent memory processing (mnemonic discrimination) over both nap and overnight sleep intervals, across the sleep transition (Aim 2); * Examine changes in sleep microstructure in both nap and overnight sleep across the sleep transition (Aim 3) * Examine interrelations among brain, memory and sleep microstructure across the sleep transition (Aim 4)

Eligibility criteria

Qualifiers

36-60 months at the time of enrollment

must be a habitual napper (defined as napping 5 or more days/week on average for the past month)

must sleep independently (not bedsharing; in order to maintain consistent sleep not interrupted by others)

Disqualifiers

diagnosis of any sleep disorder (other than mild parasomnia which is routine at this age) past or present (Child's Sleep Habit Questionnaire)

current use of psychotropic or sleep-altering medications (Developmental, Health, and Environment Questionnaire)

traveling beyond 1 time zone within 1 month prior to testing (phone screening)

fever or symptoms of respiratory illness at the time of testing (phone screening)

Trial design

Treatments tested in this trial

  • nap

Treatment groups

180 Participants
are divided into 1 treatment group

Sponsors and collaborators

University of Maryland, College Park

Lead sponsor

University of Massachusetts, Amherst

Collaborator